Biosciences Research and Commercialization Center (BRCC) logo

Biosciences Research and Commercialization Center (BRCC)

North America, Michigan, United States, Kalamazoo

Description

Biosciences Research and Commercialization Center (BRCC) is a venture capital investment arm of Western Michigan University (WMU).

Investor Profile

Biosciences Research and Commercialization Center (BRCC) has made 12 investments, with 0 in the past 12 months and 8% as lead.

Stage Focus

  • Seed (58%)
  • Series Unknown (17%)
  • Series C (8%)
  • Series B (8%)
  • Series A (8%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Therapeutics
  • Medical Device
  • Clinical Trials
  • Hospital
  • Life Science
  • Information Technology
  • Innovation Management
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Biosciences Research and Commercialization Center (BRCC) frequently co-invest with?

Invest Michigan
North America, Michigan, United States, Detroit
Co-Investments: 2
Capital Community Angel Investors
North America, Michigan, United States, East Lansing
Co-Investments: 3
Michigan Angel Fund
North America, Michigan, United States, Ann Arbor
Co-Investments: 2
ExSight Ventures
North America, New York, United States, New York
Co-Investments: 3
PC
North America, New York, United States, New York
Co-Investments: 2
M
North America, Michigan, United States, Ann Arbor
Co-Investments: 3
Bios Partners
North America, Texas, United States, Fort Worth
Co-Investments: 2
Kaitai Capital
Asia, Zhejiang, China, Hangzhou
Co-Investments: 2
Grand Angels
North America, Michigan, United States, Holland
Co-Investments: 4
Blue Water Angels
North America, Michigan, United States, Midland
Co-Investments: 3

What are some of recent deals done by Biosciences Research and Commercialization Center (BRCC)?

ONL Therapeutics

Ann Arbor, Michigan, United States

ONL Therapeutics is a biopharmaceutical company dedicated to protecting vision through the protection of photoreceptors.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Series CMar 8, 2023
Amount Raised: $15,000,000
Asalyxa Bio

Southfield, Michigan, United States

Asalyxa Bio is committed to developing neutrophil targeting treatments for diseases with a high unmet medical need.

Biotechnology
SeedFeb 23, 2021
Amount Raised: $2,000,000
ONL Therapeutics

Ann Arbor, Michigan, United States

ONL Therapeutics is a biopharmaceutical company dedicated to protecting vision through the protection of photoreceptors.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Series BDec 22, 2020
Amount Raised: $46,900,000
Shoulder Innovations

Holland, Michigan, United States

Shoulder Innovations is a medical device company that develops inset glenoid fixation technology.

BiotechnologyHealth CareInformation TechnologyInnovation ManagementMedical Device
Series UnknownNov 2, 2020
Amount Raised: $21,600,000
Naitive Traits

Kalamazoo, Michigan, United States

Naitive Traits develops native genetic traits that makes corn higher-yielding, resistant to drought, and tolerant of temperature extremes.

AgricultureAgTechBiotechnologyGenetics
Series UnknownApr 30, 2020
Amount Raised: $1,429,843
Ocuphire Pharma

Farmington Hills, Michigan, United States

Ocuphire Pharma, a clinical-stage biopharmaceutical company, develops and commercializes therapies for patients with ophthalmic disorders.

BiopharmaBiotechnologyPharmaceutical
SeedJul 22, 2019
Amount Raised: $5,000,000
GreenMark Biomedical

East Lansing, Michigan, United States

GreenMark is a healthcare company providing health-based benefits using nanoparticles.

BiotechnologyClinical TrialsHealth CareHospitalMedical Device
SeedMar 20, 2019
Amount Raised: $670,000
GreenMark Biomedical

East Lansing, Michigan, United States

GreenMark is a healthcare company providing health-based benefits using nanoparticles.

BiotechnologyClinical TrialsHealth CareHospitalMedical Device
SeedJun 29, 2018
Amount Raised: $500,000
ONL Therapeutics

Ann Arbor, Michigan, United States

ONL Therapeutics is a biopharmaceutical company dedicated to protecting vision through the protection of photoreceptors.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Series AMay 17, 2017
Amount Raised: $4,250,000
Tetra Discovery

Grand Rapids, Michigan, United States

Tetra Discovery provides consulting services and research on drug discovery for diseases affecting the central nervous system.

BiotechnologyHealth CareLife Science
SeedSep 3, 2015
Amount Raised: $1,000,000